NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice

NCT02616328

TerminatedN/A

Sponsor: Hoffmann-La Roche

Conditions: Rheumatoid Arthritis

Interventions: No intervention

Countries: Saudi Arabia

This is a single-arm, open-label, non-randomized, multicenter trial to evaluate the efficacy and safety of using tocilizumab for confirmed rheumatoid arthritis participants in clinical practice.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosed with moderate-to-severe active rheumatoid arthritis (RA) for over 3 months
* Started on tocilizumab, with or without previous history of biological treatment

Exclusion Criteria:

* Pregnant or lactating women
* Treated with an investigational drug within 30 days prior to initiation of study drug
* Having a condition that, in the opinion of the investigator, could compromise the participant's safety or interfere with the study results

Locations (2)

Riyadh, Saudi Arabia
Riyadh, Saudi Arabia